Ladenburg Thalmann Financial Services’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-45
| Closed | – | – | 5219 |
|
|
2017
Q2 | $0 | Hold |
45
| – | – | ﹤0.01% | 5163 |
|
|
2017
Q1 | $0 | Sell |
45
-25
| -36% | – | ﹤0.01% | 5171 |
|
|
2016
Q4 | $0 | Hold |
70
| – | – | ﹤0.01% | 5142 |
|
|
2016
Q3 | $0 | Hold |
70
| – | – | ﹤0.01% | 5096 |
|
|
2016
Q2 | $0 | Buy |
70
+25
| +56% | – | ﹤0.01% | 5077 |
|
|
2016
Q1 | $1K | Hold |
45
| – | – | ﹤0.01% | 4657 |
|
|
2015
Q4 | $1K | Hold |
45
| – | – | ﹤0.01% | 4648 |
|
|
2015
Q3 | $1K | Hold |
45
| – | – | ﹤0.01% | 4573 |
|
|
2015
Q2 | $1K | Hold |
45
| – | – | ﹤0.01% | 4627 |
|
|
2015
Q1 | $1K | Hold |
45
| – | – | ﹤0.01% | 4551 |
|
|
2014
Q4 | $1K | Buy |
45
+20
| +80% | +$444 | ﹤0.01% | 4328 |
|
|
2014
Q3 | $1K | Hold |
25
| – | – | ﹤0.01% | 3900 |
|
|
2014
Q2 | $1K | Hold |
25
| – | – | ﹤0.01% | 3869 |
|
|
2014
Q1 | $1K | Buy |
+25
| New | +$1K | ﹤0.01% | 3729 |
|